We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+2.34%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$54.7B
AUM Growth
-$333M
Cap. Flow
-$906M
Cap. Flow %
-1.66%
Top 10 Hldgs %
14.84%
Holding
1,599
New
74
Increased
554
Reduced
585
Closed
78

Top Sells

1
DGX icon
Quest Diagnostics
DGX
+$114M
2
ORCL icon
Oracle
ORCL
+$96.1M
3
ALL icon
Allstate
ALL
+$88.6M
4
QCOM icon
Qualcomm
QCOM
+$88.3M
5
MRSH
Marsh
MRSH
+$73.9M

Sector Composition

1 Healthcare 17.55%
2 Financials 15.04%
3 Technology 12.33%
4 Energy 9.55%
5 Industrials 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$609B
$837M 1.53%
6,326,351
-444,209
-7% -$56.7M
ORCL icon
2
Oracle
ORCL
$364B
$829M 1.52%
16,531,388
-2,109,386
-11% -$96.1M
ABT icon
3
Abbott
ABT
$175B
$825M 1.51%
16,970,213
-1,455,284
-8% -$65.9M
EQR icon
4
Equity Residential
EQR
$25.9B
$822M 1.5%
12,490,913
-439,410
-3% -$28.7M
DGX icon
5
Quest Diagnostics
DGX
$23.3B
$810M 1.48%
7,288,881
-1,075,030
-13% -$114M
BNY
6
Bank of New York Mellon
BNY
$108B
$805M 1.47%
15,782,486
-702,737
-4% -$33.6M
PFE icon
7
Pfizer
PFE
$143B
$803M 1.47%
25,194,544
-822,124
-3% -$25.9M
EIX icon
8
Edison International
EIX
$29.9B
$800M 1.46%
10,235,217
-673,278
-6% -$53.9M
CA
9
DELISTED
CA, Inc.
CA
$793M 1.45%
23,016,047
-709,351
-3% -$22.9M
ALL icon
10
Allstate
ALL
$64.3B
$793M 1.45%
8,968,676
-1,045,136
-10% -$88.6M
MRK icon
11
Merck
MRK
$315B
$786M 1.44%
12,859,553
-286,291
-2% -$17.4M
NOC icon
12
Northrop Grumman
NOC
$74.1B
$784M 1.43%
3,055,002
-145,025
-5% -$36.3M
WM icon
13
Waste Management
WM
$96.1B
$784M 1.43%
10,690,903
-446,672
-4% -$32.5M
CVS icon
14
CVS Health
CVS
$137B
$781M 1.43%
9,703,401
-48,860
-0.5% -$3.86M
TFC icon
15
Truist Financial
TFC
$65.4B
$778M 1.42%
17,133,475
+291,257
+2% +$12.6M
RTN
16
DELISTED
Raytheon Company
RTN
$774M 1.42%
4,795,104
-309,345
-6% -$49M
DD
17
DELISTED
Du Pont De Nemours E I
DD
$770M 1.41%
9,540,096
-449,895
-5% -$36M
ESRX
18
DELISTED
Express Scripts Holding Company
ESRX
$758M 1.39%
11,880,919
+922,406
+8% +$57.9M
CSCO icon
19
Cisco
CSCO
$441B
$755M 1.38%
24,109,431
-652,273
-3% -$21.2M
CAH icon
20
Cardinal Health
CAH
$53.5B
$753M 1.38%
9,659,975
-208,144
-2% -$15.7M
MRSH
21
Marsh
MRSH
$87.8B
$751M 1.37%
9,632,690
-978,642
-9% -$73.9M
CVX icon
22
Chevron
CVX
$373B
$750M 1.37%
7,187,057
+99,802
+1% +$10.6M
T icon
23
AT&T
T
$152B
$745M 1.36%
26,129,738
+156,597
+0.6% +$4.62M
INTC icon
24
Intel
INTC
$478B
$737M 1.35%
21,836,205
-27,323
-0.1% -$978K
MDLZ icon
25
Mondelez International
MDLZ
$78.3B
$726M 1.33%
16,799,699
-433,173
-3% -$19.5M

Similar funds

Macquarie Group's Q2 2017 Portfolio in Review

As of Q2 2017, Macquarie Group held 1,599 positions worth $54.7B, down 0.61% from $55B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Macquarie Group's Q2 2017 filing shows 74 new, 554 increased, 585 reduced and 78 closed positions. Its largest new stake was Altaba Inc: 830,118 shares worth $45.2M. The largest sale was Quest Diagnostics, an estimated $114M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Financials and Technology.

  • Macquarie Group's largest Q2 2017 buy was Altaba Inc: 830,118 shares worth $45.2M.
  • Macquarie Group added most to Marathon Oil Corporation in Q2 2017, an estimated $399M increase.
  • Macquarie Group's biggest Q2 2017 reduction was Quest Diagnostics, cutting an estimated $114M.
  • Macquarie Group fully exited Syngenta Ag in Q2 2017, selling an estimated $69.7M.
  • Macquarie Group's ten largest holdings make up 15% of its $54.7B portfolio in Q2 2017.
  • Macquarie Group opened 74 new positions and closed 78 in Q2 2017.
  • Macquarie Group's portfolio value fell 0.61% quarter-over-quarter to $54.7B.

Based on Macquarie Group's 13F filing for Q2 2017, filed 14 Aug 2017.